Reverse cholesterol transport and cholesterol efflux in atherosclerosis (Q36300834)

13 August 2017

1 reference

title

Reverse cholesterol transport and cholesterol efflux in atherosclerosis (English)

1 reference

13 August 2017

1 reference

Ohashi R

1

1 reference

13 August 2017

Mu H

2

1 reference

13 August 2017

Wang X

3

1 reference

13 August 2017

Yao Q

4

1 reference

13 August 2017

Chen C

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

28 October 2005

1 reference

QJM: An International Journal of Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

98

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

845-856

1 reference

Atherosclerosis — An Inflammatory Disease

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Genetic basis of atherosclerosis: part I: new genes and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Genetic basis of atherosclerosis: part II: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Cholesterol and plant sterol absorption: recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Caveolin, cholesterol, and lipid bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Scavenger receptor BI and cholesterol trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

VIP21/caveolin is a cholesterol-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Expression of caveolin-1 enhances cholesterol efflux in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Apolipoprotein A-I(Milano): current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Homozygous Tangier disease and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

The safety and immunogenicity of a CETP vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Remodelling of high density lipoproteins by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

The impact of phospholipid transfer protein (PLTP) on HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Enhanced cholesterol efflux promotion in well-trained soccer players

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Acceleration of reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Study of ABCA1 function in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Control of cholesterol turnover in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Hormonal regulation of apolipoprotein AI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCI136

21 January 2018

Identifiers

DOI

10.1093/QJMED/HCI136

1 reference

13 August 2017

1 reference